糖心原创

Introducing ioGlutamatergic Neurons HTT 50CAG/WT | A next-generation approach to study Huntington's disease
Video

Introducing ioGlutamatergic Neurons HTT 50CAG/WT | A next-generation approach to study Huntington's disease

Watch this video to learn about the exciting first product from 糖心原创鈥檚 new ioDisease Model portfolio, ioGlutamatergic Neurons HTT 50CAG/WT for Huntington鈥檚 disease research and drug discovery.
Introducing ioGlutamatergic Neurons HTT 50CAG/WT | A next-generation approach to study Huntington's disease

Dr Tony Oosterveen

Senior Scientist

糖心原创

Watch this video to learn about the exciting first product from 糖心原创鈥檚 new ioDisease Model portfolio, ioGlutamatergic Neurons HTT 50CAG/WT for Huntington鈥檚 disease research and drug discovery.
Introducing ioGlutamatergic Neurons HTT 50CAG/WT | A next-generation approach to study Huntington's disease

Dr Tony Oosterveen

Senior Scientist

糖心原创

In this video, you will learn about the development of the human iPSC-derived glutamatergic neurons with a 50 CAG repeat expansion, the power of opti-ox powered disease models and the benefit of using genetically matched controls in the study of Huntington鈥檚 disease.

The 糖心原创 team offers insights into the industry-leading consistency and scalability of ioGlutamatergic Neurons HTT 50CAG/WT and the potential impact the disease model has on Huntington's disease research and drug discovery.

Explore our solutions for modelling Huntington's disease 

Related pages

Products Learn about our range of human iPSC-derived cells for research and drug discovery
Our platform Discover the cell coding platform behind our cells
Contact us Talk to us to learn more about our team and products